NVDA
NVIDIA Corporation
NVDA has the edge over VRSN overall, supported by stronger valuation and stronger modeled upside.
VRSN
VeriSign, Inc.
VRSN's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
VRSN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
VRSN's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over VRSN in the historical PE scenario, which offers more potential upside but is not a forecast.
VRSN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 25x | $228 | -27% |
| Forward | 29x | $312 | — |
| Fair | 30x | $282 | -9.6% |
| Current | 34x | $312 | — |
| Expensive | 35x | $326 | +4.3% |
Historical ranges are pointers, not guarantees.
VRSN's PE is in its expensive range at 34x. If earnings grow as analysts expect, today's price would be 29x next year's earnings, in its fair range.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
VRSN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
VRSN has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over VRSN on earnings, with more consistent year-over-year improvement.
VRSN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.86 | +17% |
| Q3 2026 | $9.30 | +8.4% |
| Q2 2026 | $9.22 | +10% |
| Q1 2026 | $9.05 | +11% |
| Q4 2025 | $8.81 | +10% |
| Q3 2025 | $8.58 | 0% |
| Q2 2025 | $8.38 | +0.5% |
| Q1 2025 | $8.18 | +0.7% |
| Q4 2024 | $8.00 | +1.3% |
VRSN earned $9.30 per share over the past year, up 8.4% from the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over VRSN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA's operating margin was 66% last quarter, up 5.4 points from the same quarter a year ago, near the top of its range since 2019.
VRSN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $443M | +5.7% |
| Q2 2026 | $434.6M | +6% |
| Q1 2026 | $428.9M | +6.6% |
| Q4 2025 | $425.3M | +7.6% |
| Q3 2025 | $419.1M | +7.3% |
| Q2 2025 | $409.9M | +5.9% |
| Q1 2025 | $402.3M | +4.7% |
| Q4 2024 | $395.4M | +3.9% |
VRSN's revenue has grown year over year every quarter since late 2020: $443M last quarter, up 5.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 67% | -0.9 points |
| Q2 2026 | 68% | -0.3 points |
| Q1 2026 | 68% | +1 points |
| Q4 2025 | 67% | +0.2 points |
| Q3 2025 | 68% | -1.1 points |
| Q2 2025 | 68% | -0.3 points |
| Q1 2025 | 67% | 0 points |
| Q4 2024 | 67% | -0.7 points |
VRSN has the edge over NVDA on profitability, with a higher operating margin.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over VRSN on cash flow, with more consistent year-over-year improvement.
VRSN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $260.7M | -14% |
| Q2 2026 | $212.8M | +9.3% |
| Q1 2026 | $265.2M | -7.1% |
| Q4 2025 | $285.1M | +28% |
| Q3 2025 | $303M | +22% |
| Q2 2025 | $194.7M | +29% |
| Q1 2025 | $285.5M | +13% |
| Q4 2024 | $222M | +11% |
VRSN's free cash flow has been positive every quarter for six years: $1B over the past year, up 1.9% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
VRSN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -700K shares |
| 1 year | -3.4% | -3.2M shares |
| 3 years | -12% | -12.6M shares |
| 5 years | -19% | -21.4M shares |
| Available history | -24% | -28.6M shares |
VRSN has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $193.2M |
| Q2 2026 | $201.4M |
| Q1 2026 | $225.4M |
| Q4 2025 | $254.4M |
| Q3 2025 | $218.7M |
| Q2 2025 | $166.8M |
| Q1 2025 | $241.7M |
| Q4 2024 | $262.3M |
VRSN spent $874M buying back its own shares over the past year, down 1.7% from the year before.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VRSN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | 1.5x | Healthy |
VRSN has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
VRSN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 78.0 | Neutral |
VRSN's weekly RSI is 64 (neutral) and its Stochastic is 78 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over VRSN on valuation relative to its sector.
VRSN PE vs Technology Sector
| Metric | VRSN | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 28x | 21% above |
| PE % | 74 | 35 | 39 pts above |
VRSN is trading at 34x earnings, a 21% premium to the Technology sector's median of 28x.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
VRSN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $301.3 | 3.7% above |
| 20 week MA | $291.3 | 7.3% above |
| 50 week MA | $270.2 | 16% above |
| 100 week MA | $263.2 | 19% above |
| 200 week MA | $230.6 | 36% above |
VRSN has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
VRSN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $194.1 | $214.6 | +11% |
| 2021 | $214.6 | $249.6 | +16% |
| 2022 | $249.6 | $203.7 | -18% |
| 2023 | $203.7 | $206.0 | +1.1% |
| 2024 | $206.0 | $204.0 | -1% |
| 2025 | $204.0 | $246.3 | +21% |
| 2026 YTD | $246.3 | $312.5 | +27% |
VRSN has the edge over NVDA on returns for 2026, with the stronger performance.